Covered recipient · General Payments record
RICHARD S SPRAGUE
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2023
$2,438.96
- Reported across 145 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $229.42 | 12 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $157.51 | 9 |
| Alnylam Pharmaceuticals Inc. | $27.99 | 1 |
| Celgene Corporation | $25.49 | 1 |
| IRONWOOD PHARMACEUTICALS, INC | $18.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $14.65 | 01/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999092381 | CMS |
| AbbVie Inc. | $12.64 | 01/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999092385 | CMS |
| AbbVie Inc. | $15.30 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999092389 | CMS |
| AbbVie Inc. | $11.71 | 02/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999092393 | CMS |
| AbbVie Inc. | $12.88 | 02/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999092397 | CMS |
| AbbVie Inc. | $19.24 | 03/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999092401 | CMS |
| AbbVie Inc. | $21.04 | 04/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999092405 | CMS |
| AbbVie Inc. | $19.81 | 04/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999092409 | CMS |
| AbbVie Inc. | $30.24 | 05/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999092413 | CMS |
| Alnylam Pharmaceuticals Inc. | $27.99 | 01/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006170507 | CMS |
| Celgene Corporation | $25.49 | 04/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1016418739 | CMS |
| Ironwood Pharmaceuticals, Inc | $18.43 | 03/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1045513965 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.